Stay updated on Gilead Sciences Press Releases

Sign up to get notified when there's something new on the Gilead Sciences Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Gilead Sciences Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    New press releases were added, including the 3.8 percent increase in the first quarter 2026 dividend and the fourth quarter and full-year 2025 financial results, plus an FDA label update for Yescarta; several older press releases were removed from the listings.
    Difference
    5%
    Check dated 2026-02-11T16:32:32.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Footer copyright year updated from 1996-2025 to 1996-2026.
    Difference
    0.3%
    Check dated 2026-02-04T10:55:39.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    New items were added to the News Releases list, including January 27, 2026 and January 21, 2026 disclosures, while an older December 2025 entry and two Kite-related entries were removed.
    Difference
    4%
    Check dated 2026-01-28T06:25:32.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The News Releases list has new items added (e.g., December 2025 releases), expanding the current announcements. The overall layout and navigation remain unchanged.
    Difference
    0.5%
    Check dated 2026-01-14T03:03:49.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    New December 2025 press releases appear in the News Releases list (e.g., Dec 22, 2025; Dec 19, 2025; Dec 18, 2025) and several November 2025 items have been removed; the page structure and navigation remain the same.
    Difference
    5%
    Check dated 2025-12-23T20:44:30.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    News Releases is replaced by Newsroom, and a new December 15, 2025 press release titled 'Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial' is added. The November 7, 2025 entry 'Gilead Provides Update on Phase 3 ASCENT-07 Study' is removed.
    Difference
    4%
    Check dated 2025-12-16T18:45:00.000Z thumbnail image

Stay in the know with updates to Gilead Sciences Press Releases

Enter your email address, and we'll notify you when there's something new on the Gilead Sciences Press Releases page.